Serena S. Kwek

4.0k citations

27 papers · 2.3k indexed · 2 hit papers · h-index 20

Oncology top 2%
Immunology top 2%
Molecular Biology top 10%
Pulmonary and Respiratory Medicine top 10%
Cancer Research top 10%

Co-authors: Lawrence Fong Matthew H. Spitzer Edgar G. Engleman Garry P. Nolan Yaron Carmi Maria M. Martins Nathan E. Reticker-Flynn Deepthi Madhireddy
Topics: Cancer Immunotherapy and Biomarkers (13 papers)CAR-T cell therapy research (10 papers)Immunotherapy and Immune Responses (9 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Cell Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States Israel Australia

In The Last Decade

Serena S. Kwek

26 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic Immunity Is Required for Effective Cancer Immunotherapy

2017 687 citations Matthew H. Spitzer, Yaron Carmi et al. Cell profile →
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

2020 464 citations David Y. Oh, Serena S. Kwek et al. Cell profile →

Peers

Countries citing papers authored by Serena S. Kwek

Since Specialization

Citations

This map shows the geographic impact of Serena S. Kwek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena S. Kwek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena S. Kwek more than expected).

Fields of papers citing papers by Serena S. Kwek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena S. Kwek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena S. Kwek. The network helps show where Serena S. Kwek may publish in the future.

Co-authorship network of co-authors of Serena S. Kwek

This figure shows the co-authorship network connecting the top 25 collaborators of Serena S. Kwek. A scholar is included among the top collaborators of Serena S. Kwek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena S. Kwek. Serena S. Kwek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer 2025 ·JCI Insight ·Serena S. Kwek,Hai Yang,Tony Li,Arielle Ilano,Eric D. Chow,Li Zhang,(unknown),(unknown),Averey Lea,Matthew Clark,(unknown),Yimin Shi,Elizabeth A. McCarthy,Sima P. Porten,Maxwell V. Meng,Chun Ye,Lawrence Fong,David Oh	0
2	Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4 2025 ·JCI Insight ·Marcel Arias-Badia,Peixi Chen,(unknown),(unknown),Aram Lyu,(unknown),Serena S. Kwek,(unknown),(unknown),(unknown),Matthew D. Clark,Averey Lea,(unknown),Andrew Goodearl,Fiona Harding,Jacob V. Gorman,(unknown),Lawrence Fong	2
3	CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy 2024 ·Blood Advances ·Guy Ledergor,(unknown),Kaichun Wu,Elizabeth McCarthy,Axel Hyrenius‐Wittsten,(unknown),(unknown),(unknown),Serena S. Kwek,Alexander Cheung,Sophia Bylsma,Erik Hansen,Jeffrey L. Wolf,Sandy W. Wong,Nina Shah,Kole T. Roybal,Thomas Martin,Chun Ye,Lawrence Fong	19
4	Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer 2024 ·Cancer Immunology Research ·(unknown),(unknown),Brandon K. Chen,(unknown),Michael L. Cheng,Eric Liu,(unknown),Li Zhang,Meenal Sinha,Alexander Cheung,Serena S. Kwek,Eric D. Chow,(unknown),Rahul Aggarwal,Terence W. Friedlander,Eric J. Small,Mark S. Anderson,Lawrence Fong	3
5	Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function 2023 ·Nature Immunology ·Chiara Rancan,Marcel Arias-Badia,Pranay Dogra,Brandon Chen,Dvir Aran,Hai Yang,(unknown),Arielle Ilano,(unknown),(unknown),Serena S. Kwek,Li Zhang,Lewis L. Lanier,Maxwell V. Meng,Donna L. Färber,Lawrence Fong	44
6	Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma 2021 ·Cancer Immunology Immunotherapy ·Rosanna Wustrack,(unknown),(unknown),Melissa N. Zimel,Soo‐Jin Cho,Andrew Horvai,(unknown),Serena S. Kwek,Lawrence Fong,Ross A. Okimoto	9
7	Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancerbreakdown → 2020 ·Cell ·David Y. Oh,Serena S. Kwek,Siddharth S. Raju,Tony Li,Elizabeth McCarthy,Eric D. Chow,Dvir Aran,Arielle Ilano,Chien-Chun Steven Pai,Chiara Rancan,Kathryn M. Allaire,(unknown),Yang Sun,Matthew H. Spitzer,Serghei Mangul,Sima P. Porten,Maxwell V. Meng,Terence W. Friedlander,Chun Ye,Lawrence Fong	464
8	Systemic Immunity Is Required for Effective Cancer Immunotherapybreakdown → 2017 ·Cell ·Matthew H. Spitzer,Yaron Carmi,Nathan E. Reticker-Flynn,Serena S. Kwek,Deepthi Madhireddy,Maria M. Martins,Pier Federico Gherardini,Tyler R. Prestwood,Jonathan Chabon,Sean C. Bendall,Lawrence Fong,Garry P. Nolan,Edgar G. Engleman	687
9	Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer 2016 ·Cancer Immunology Research ·Xiao X. Wei,(unknown),Serena S. Kwek,Jera Lewis,Vinh Dao,Li Zhang,Matthew R. Cooperberg,Charles J. Ryan,Amy Lin,Terence W. Friedlander,Brian Rini,Christopher Kane,Jeffry Simko,Peter R. Carroll,Eric J. Small,Lawrence Fong	30
10	Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire 2016 ·Cancer Research ·David Y. Oh,Jason Cham,Li Zhang,(unknown),Serena S. Kwek,Mark Klinger,Malek Faham,Lawrence Fong	173
11	Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab 2015 ·Cancer Immunology Research ·Serena S. Kwek,Jera Lewis,Li Zhang,Vivian Weinberg,(unknown),Andrea Harzstark,Amy Lin,Charles J. Ryan,Eric J. Small,Lawrence Fong	50
12	GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses 2015 ·OncoImmunology ·Serena S. Kwek,James G. Kahn,(unknown),Jera Lewis,Edward Cha,Li Zhang,Robert Weber,(unknown),Svetomir N. Markovic,Lawrence Fong,Lynn E. S̄pitler	29
13	Unmasking the immune recognition of prostate cancer with CTLA4 blockade 2012 ·Nature reviews. Cancer ·Serena S. Kwek,Edward Cha,Lawrence Fong	41
14	An aberrant prostate antigen–specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans 2009 ·Journal of Clinical Investigation ·Yafei Hou,Jason DeVoss,(unknown),Serena S. Kwek,Jeffrey P. Simko,Douglas G. McNeel,Mark S. Anderson,Lawrence Fong	47
15	Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis 2009 ·Oncogene ·Serena S. Kwek,Ritu Roy,(unknown),Joan Climent,José A. Martínez-Climent,Jane Fridlyand,Donna G. Albertson	76
16	Genome position and gene amplification 2007 ·Genome biology ·(unknown),Antoine M. Snijders,Serena S. Kwek,Ritu Roydasgupta,Jane Fridlyand,Taku A. Tokuyasu,Daniel Pinkel,Donna G. Albertson	21
17	Apoptosis Inhibitor as a Suppressor of Tumor Progression: Expression of Bcl-2 Eliminates Selective Advantages for p53-Deficient Cells in the Tumor 2002 ·Cancer Biology & Therapy ·Katerina V. Gurova,Serena S. Kwek,Igor Koman,Andrei P. Komarov,Eugene Kandel,Mikhail A. Nikiforov,Andrei V. Gudkov	25
18	Functional analysis and intracellular localization of p53 modified by SUMO-1 2001 ·Oncogene ·Serena S. Kwek,(unknown),Angela L. Tyner,Zhiyuan Shen,Andrei V. Gudkov	109
19	Structure and Regulation of the Mouse ing1 Gene 1999 ·Journal of Biological Chemistry ·Marija Zeremski,Jason E. Hill,Serena S. Kwek,Irina A. Grigorian,Katerina V. Gurova,Igor Garkavtsev,Luda Diatchenko,Eugene V. Koonin,Andrei V. Gudkov	59
20	Suppression of apoptosis by bcl-2 does not prevent p53-mediated control of experimental metastasis and anchorage dependence 1997 ·Oncogene ·Mikhail A. Nikiforov,Serena S. Kwek,(unknown),James E. Artwohl,Scott Lowe,Tapas K. Das Gupta,Г. И. Дейчман,Andrei V. Gudkov	21

About Serena S. Kwek

Serena S. Kwek is a scholar working on Oncology, Immunology and Equine, having authored 27 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.5k citations) and Cancer Research (236 citations). Serena S. Kwek has collaborated with scholars based in United States, Israel and Australia. Frequent co-authors include Lawrence Fong, Matthew H. Spitzer, Edgar G. Engleman, Garry P. Nolan, Yaron Carmi, Maria M. Martins, Nathan E. Reticker-Flynn, Deepthi Madhireddy, Tyler R. Prestwood and Pier Federico Gherardini. Their work appears in journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact